Redeye: Hexatronic Group - A Criticial Business

Redeye reiterates its positive long-term stance on Hexatronic on the back of solid Q1-figures, the key take-away of which was the strong order book growth 35% y/y. While the potential near-term fallout from the corona crisis is difficult to gauge, we believe investors should look to the company’s underlying momentum in its strategic growth markets.

Read more and download the research update: https://bit.ly/3ceqWGn

Start following companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/